BRAINSTORM CELL THERAPEUTICS INC. Annual Return On Equity in % from 2011 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Brainstorm Cell Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2011 to 2024.
  • Brainstorm Cell Therapeutics Inc. Return On Equity for the quarter ending December 31, 2024 was 203 %, a 52.3% decline year-over-year.
  • Brainstorm Cell Therapeutics Inc. annual Return On Equity for 2024 was 203 %, a 52.3% decline from 2023.
  • Brainstorm Cell Therapeutics Inc. annual Return On Equity for 2023 was 425 %.
  • Brainstorm Cell Therapeutics Inc. annual Return On Equity for 2022 was -469 %, a 430% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 203 -222 -52.3% Jan 1, 2024 Dec 31, 2024
2023 425 +894 Jan 1, 2023 Dec 31, 2023
2022 -469 -380 -430% Jan 1, 2022 Dec 31, 2022
2021 -88.4 +70.1 +44.2% Jan 1, 2021 Dec 31, 2021
2020 -159 -560 -140% Jan 1, 2020 Dec 31, 2020
2019 401 +577 Jan 1, 2019 Dec 31, 2019
2018 -176 -102 -136% Jan 1, 2018 Dec 31, 2018
2017 -74.4 -30 -67.6% Jan 1, 2017 Dec 31, 2017
2016 -44.4 +6.15 +12.2% Jan 1, 2016 Dec 31, 2016
2015 -50.6 +86.2 +63% Jan 1, 2015 Dec 31, 2015
2014 -137 +12.7 +8.48% Jan 1, 2014 Dec 31, 2014
2013 -149 -5.22 -3.62% Jan 1, 2013 Dec 31, 2013
2012 -144 +35.1 +19.6% Jan 1, 2012 Dec 31, 2012
2011 -179 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.